https://www.cancernetwork.com/view/ctim-76-receives-fda-fast-track-status-in-platinum-resistant-ovarian-cancer2026-04-03T14:30:00Z2026-04-03T14:30:00Z https://www.cancernetwork.com/view/elcc-2026-key-updates-across-non-small-cell-lung-cancer-populations2026-04-03T14:00:00Z2026-04-03T14:00:00Z https://www.cancernetwork.com/view/implementing-patient-education-and-supportive-care-in-egfr-mutated-metastatic-non-small-cell-lung-cancer2026-04-03T12:05:00Z2026-04-03T12:05:00Z https://www.cancernetwork.com/view/subcutaneous-amivantamab-lazertinib-a-new-soc-in-egfr-nsclc-2026-04-03T12:00:00Z2026-04-03T12:00:00Z https://www.cancernetwork.com/view/access-adherence-and-dosing-flexibility-in-egfr-mutated-metastatic-non-small-cell-lung-cancer2026-04-03T12:00:00Z2026-04-03T12:00:00Z https://www.cancernetwork.com/view/car-t-moves-to-the-front-line-rethinking-the-multiple-myeloma-sequence2026-04-02T20:00:00Z2026-04-02T20:00:00Z https://www.cancernetwork.com/view/optimizing-oxybutynin-doses-for-adt-induced-hot-flashes-in-prostate-cancer2026-04-02T19:00:00Z2026-04-02T19:00:00Z https://www.cancernetwork.com/view/plixorafenib-receives-fda-btd-for-braf-v600e-mutated-high-grade-glioma2026-04-02T17:29:38.735Z2026-04-02T17:29:38.735Z https://www.cancernetwork.com/view/emerald-3-durvalumab-combo-improves-pfs-in-embolization-eligible-hcc2026-04-02T16:06:41.478Z2026-04-02T16:06:41.478Z https://www.cancernetwork.com/view/urine-based-biopsy-shows-97-8-sensitivity-in-prostate-cancer-detection2026-04-02T15:30:00Z2026-04-02T15:30:00Z https://www.cancernetwork.com/view/highlighting-oxybutynin-impact-on-adt-induced-hot-flashes-in-prostate-cancer2026-04-02T15:00:00Z2026-04-02T15:00:00Z https://www.cancernetwork.com/view/fda-approves-brexucabtagene-autoleucel-in-adult-r-r-mcl2026-04-02T14:45:29.648Z2026-04-02T14:45:29.648Z https://www.cancernetwork.com/view/fda-extends-review-period-for-orca-t-in-hematologic-malignancies2026-04-02T14:30:00Z2026-04-02T14:30:00Z https://www.cancernetwork.com/view/a-multicenter-quality-audit-standardizing-esophageal-contouring-in-postmastectomy-radiotherapy2026-04-02T12:00:00Z2026-04-02T12:00:00Z https://www.cancernetwork.com/view/discussing-a-phase-2-defactinib-avutometinib-trial-in-diffuse-gastric-cancer2026-04-01T22:00:00Z2026-04-01T22:00:00Z https://www.cancernetwork.com/view/highlighting-emerging-genitourinary-cancer-research-at-columbia-university2026-04-01T21:00:00Z2026-04-01T21:00:00Z https://www.cancernetwork.com/view/rethinking-dual-targeting-durability-after-car-t-in-non-hodgkin-lymphoma2026-04-01T18:00:00Z2026-04-01T18:00:00Z https://www.cancernetwork.com/view/anbenitamab-injection-combo-meets-pcr-end-point-in-her2-breast-cancer2026-04-01T17:00:31.835Z2026-04-01T17:00:31.835Z https://www.cancernetwork.com/view/dna-rna-based-ngs-test-improves-diagnostic-accuracy-in-bile-duct-strictures2026-04-01T16:00:00Z2026-04-01T16:00:00Z https://www.cancernetwork.com/view/third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population2026-04-01T14:54:18.810Z2026-04-01T14:54:18.810Z https://www.cancernetwork.com/view/the-rise-of-early-onset-cancers-investigating-breast-and-crc-occurrences2026-04-01T14:00:00Z2026-04-01T14:00:00Z https://www.cancernetwork.com/view/osimertinib-across-stages-shaping-early-stage-egfr-mutated-nsclc-care2026-04-01T12:05:00Z2026-04-01T12:05:00Z https://www.cancernetwork.com/view/debate-round-1-should-car-t-be-given-inpatient-or-outpatient2026-04-01T12:00:00Z2026-04-01T12:00:00Z https://www.cancernetwork.com/view/egfr-biology-and-treatment-selection-beyond-pd-l1-in-egfr-mutated-nsclc2026-04-01T12:00:00Z2026-04-01T12:00:00Z https://www.cancernetwork.com/view/a-look-behind-the-curtain-what-is-the-radonc-review-2026-04-01T12:00:00Z2026-04-01T12:00:00Z https://www.cancernetwork.com/view/global-health-award-will-expand-prostate-cancer-care-to-nigeria2026-03-31T21:00:00Z2026-03-31T21:00:00Z https://www.cancernetwork.com/view/endometrial-cancer-treatment-options-what-are-the-experts-using-2026-03-31T16:00:00Z2026-03-31T16:00:00Z https://www.cancernetwork.com/view/doxorubicin-microneedle-array-shows-positive-response-in-skin-cancer-subtype2026-03-31T15:30:00Z2026-03-31T15:30:00Z https://www.cancernetwork.com/view/fda-grants-priority-review-to-lirafugratinib-in-fgfr2-cholangiocarcinoma2026-03-31T15:21:20.759Z2026-03-31T15:21:20.759Z https://www.cancernetwork.com/view/litespark-011-regimen-potentially-a-new-soc-in-pd-1-pretreated-ccrcc-2026-03-31T15:00:00Z2026-03-31T15:00:00Z https://www.cancernetwork.com/view/perspectives-from-the-ever-changing-multidisciplinary-oncology-field2026-03-31T14:00:00Z2026-03-31T14:00:00Z https://www.cancernetwork.com/view/unmet-needs-in-early-relapse-multiple-myeloma2026-03-31T12:15:00Z2026-03-31T12:15:00Z https://www.cancernetwork.com/view/how-rapid-therapeutic-evolution-has-complicated-rcc-sequencing2026-03-31T12:15:00Z2026-03-31T12:15:00Z https://www.cancernetwork.com/view/frontline-regimen-selection-in-advanced-renal-cell-carcinoma2026-03-31T12:15:00Z2026-03-31T12:15:00Z https://www.cancernetwork.com/view/elevating-individualized-care-on-colorectal-cancer-awareness-month2026-03-31T12:00:00Z2026-03-31T12:00:00Z https://www.cancernetwork.com/view/first-line-treatment-selection-in-advanced-renal-cell-carcinoma2026-03-31T12:00:00Z2026-03-31T12:00:00Z https://www.cancernetwork.com/view/defining-early-relapse-and-treatment-selection-in-multiple-myeloma2026-03-31T12:00:00Z2026-03-31T12:00:00Z https://www.cancernetwork.com/view/framing-litespark-011-in-a-changing-rcc-landscape2026-03-31T12:00:00Z2026-03-31T12:00:00Z https://www.cancernetwork.com/view/apos-president-highlights-focus-on-expanding-access-education2026-03-30T21:00:00Z2026-03-30T21:00:00Z https://www.cancernetwork.com/view/managing-relapsed-refractory-follicular-lymphoma-overview-and-unmet-needs2026-03-30T20:00:06.283Z2026-03-30T20:00:06.283Z https://www.cancernetwork.com/view/optimizing-therapeutic-strategies-across-treatment-lines-in-advanced-rcc2026-03-30T19:00:00Z2026-03-30T19:00:00Z https://www.cancernetwork.com/view/reprogramming-t-cells-the-promise-of-in-vivo-site-specific-car-engineering2026-03-30T18:00:00Z2026-03-30T18:00:00Z https://www.cancernetwork.com/view/mitomycin-exhibits-sustained-24-month-survival-in-nmibc-population2026-03-30T17:00:00Z2026-03-30T17:00:00Z https://www.cancernetwork.com/view/nivolumab-based-treatment-yields-long-term-survival-in-resectable-nsclc2026-03-30T16:00:00Z2026-03-30T16:00:00Z https://www.cancernetwork.com/view/fda-grants-fast-track-designation-to-fr-adc-in-advanced-proc2026-03-30T14:53:19.747Z2026-03-30T14:53:19.747Z https://www.cancernetwork.com/view/lifesaving-upgrades-reviewing-40-years-of-fda-oncology-approvals2026-03-30T14:00:00Z2026-03-30T14:00:00Z https://www.cancernetwork.com/view/providing-support-for-mental-health-disorders-across-cancer-populations2026-03-30T12:00:00Z2026-03-30T12:00:00Z https://www.cancernetwork.com/view/novel-kras-g12d-targeted-agent-shows-early-activity-in-kras-nsclc2026-03-29T16:00:00Z2026-03-29T16:00:00Z https://www.cancernetwork.com/view/3-things-you-should-know-about-treating-paraneoplastic-lambert-eaton-myasthenic-syndrome2026-03-29T14:00:00Z2026-03-29T14:00:00Z https://www.cancernetwork.com/view/osimertinib-combo-boosts-pfs-in-egfr-tp53-nsclc-trial2026-03-28T18:00:00Z2026-03-28T18:00:00Z https://www.cancernetwork.com/view/3-things-you-should-know-about-epithelioid-sarcoma2026-03-28T14:00:00Z2026-03-28T14:00:00Z https://www.cancernetwork.com/view/elucidating-mindfulness-impacts-on-qol-psychosocial-symptoms-in-oncology2026-03-27T18:00:00Z2026-03-27T18:00:00Z https://www.cancernetwork.com/view/berzosertib-combo-displays-safety-and-tolerability-in-head-and-neck-cancer2026-03-27T17:00:00Z2026-03-27T17:00:00Z https://www.cancernetwork.com/view/low-dose-ct-screening-reduces-lung-cancer-specific-mortality2026-03-27T15:35:57.755Z2026-03-27T15:35:57.755Z https://www.cancernetwork.com/view/fda-approves-companion-diagnostic-for-pembrolizumab-in-esophageal-gej-carcinoma2026-03-27T14:53:53.694Z2026-03-27T14:53:53.694Z https://www.cancernetwork.com/view/proactive-toxicity-management-and-dose-modification-in-egfr-mutated-metastatic-non-small-cell-lung-cancer2026-03-27T12:05:00Z2026-03-27T12:05:00Z https://www.cancernetwork.com/view/beyond-the-manuscript-how-social-media-is-redefining-the-modern-oncologist2026-03-27T12:00:00Z2026-03-27T12:00:00Z https://www.cancernetwork.com/view/subcutaneous-administration-in-egfr-mutated-metastatic-non-small-cell-lung-cancer2026-03-27T12:00:00Z2026-03-27T12:00:00Z https://www.cancernetwork.com/view/single-agent-doxorubicin-adjuvant-chemotherapy-for-resectable-grade-2-3-soft-tissue-sarcomas-a-retrospective-study2026-03-26T22:00:00Z2026-03-26T22:00:00Z https://www.cancernetwork.com/view/scaling-integrative-oncology-implementation-and-patient-reported-outcomes2026-03-26T21:00:00Z2026-03-26T21:00:00Z https://www.cancernetwork.com/view/strategies-for-managing-cancer-related-fatigue-impact-on-cognitive-function2026-03-26T19:00:00Z2026-03-26T19:00:00Z https://www.cancernetwork.com/view/durvalumab-sbrt-may-limit-tumor-progression-in-early-stage-nsclc2026-03-26T17:28:23.029Z2026-03-26T17:28:23.029Z https://www.cancernetwork.com/view/csf-liquid-biopsy-displays-82-clinical-impact-in-cns-lymphoma2026-03-26T16:00:00Z2026-03-26T16:00:00Z https://www.cancernetwork.com/view/adjuvant-atezolizumab-mfolfox6-improves-dfs-in-stage-iii-dmmr-colon-cancer2026-03-26T15:21:05.376Z2026-03-26T15:21:05.376Z https://www.cancernetwork.com/view/novel-small-molecule-earns-fda-fast-track-designation-in-alk-nsclc2026-03-26T14:30:36.136Z2026-03-26T14:30:36.136Z https://www.cancernetwork.com/view/teclistamab-combo-approval-affirms-role-of-anti-bcma-therapy-in-myeloma2026-03-26T14:00:00Z2026-03-26T14:00:00Z https://www.cancernetwork.com/view/how-will-data-from-asco-gu-2026-impact-the-treatment-paradigm-2026-03-26T12:00:00Z2026-03-26T12:00:00Z https://www.cancernetwork.com/view/cbt-framework-shows-feasibility-in-pediatric-oncology-caregivers2026-03-25T21:00:00Z2026-03-25T21:00:00Z https://www.cancernetwork.com/view/when-to-consider-a-re-biopsy-in-the-metastatic-crpc-treatment-course2026-03-25T19:00:00Z2026-03-25T19:00:00Z https://www.cancernetwork.com/view/imnn-001-plus-neoadjuvant-chemo-improves-os-in-advanced-ovarian-cancer2026-03-25T18:00:02.722Z2026-03-25T18:00:02.722Z https://www.cancernetwork.com/view/nadofaragene-firadenovec-label-update-approved-in-bcg-unresponsive-nmibc2026-03-25T16:00:00Z2026-03-25T16:00:00Z https://www.cancernetwork.com/view/being-a-pediatric-intern-doctor-in-south-sudan-clinical-lessons-from-a-resource-limited-hospital2026-03-25T15:00:00Z2026-03-25T15:00:00Z https://www.cancernetwork.com/view/bevacizumab-biosimilar-shows-clinical-equivalence-in-advanced-nsclc2026-03-25T14:30:08.053Z2026-03-25T14:30:08.053Z https://www.cancernetwork.com/view/fda-approves-relacorilant-combo-in-platinum-resistant-ovarian-cancers2026-03-25T14:30:07.786Z2026-03-25T14:30:07.786Z https://www.cancernetwork.com/view/when-the-world-stopped-a-lesson-in-strength-and-second-chances2026-03-25T14:00:00Z2026-03-25T14:00:00Z https://www.cancernetwork.com/view/neoadjuvant-strategies-and-early-biomarker-testing-in-egfr-mutated-nsclc2026-03-25T12:15:00Z2026-03-25T12:15:00Z https://www.cancernetwork.com/view/us-registry-comparing-second-line-car-t-products-in-lbcl2026-03-25T12:00:00Z2026-03-25T12:00:00Z https://www.cancernetwork.com/view/evolving-adjuvant-therapy-in-early-stage-egfr-mutated-nsclc-insights-from-adaura2026-03-25T12:00:00Z2026-03-25T12:00:00Z https://www.cancernetwork.com/view/navigating-new-horizons-in-neuroendocrine-prostate-cancer2026-03-24T22:00:00Z2026-03-24T22:00:00Z https://www.cancernetwork.com/view/the-intersection-of-technology-and-psycho-oncology-care2026-03-24T20:00:23.378Z2026-03-24T20:00:23.378Z https://www.cancernetwork.com/view/investigating-differences-between-esophagogastric-cancers-across-age-groups2026-03-24T18:00:00Z2026-03-24T18:00:00Z https://www.cancernetwork.com/view/optimizing-longitudinal-cardiac-monitoring-in-breast-cancer-chemotherapy2026-03-24T17:00:00Z2026-03-24T17:00:00Z https://www.cancernetwork.com/view/fda-clears-investigator-initiated-ind-for-srn-101-in-recurrent-high-grade-glioma2026-03-24T16:45:27.686Z2026-03-24T16:45:27.686Z https://www.cancernetwork.com/view/selinexor-combo-improves-spleen-volume-reduction-in-myelofibrosis2026-03-24T14:15:00Z2026-03-24T14:15:00Z https://www.cancernetwork.com/view/the-evolution-of-artificial-intelligence-in-oncology-impact-on-trials-workflows-and-outcomes2026-03-24T14:00:00Z2026-03-24T14:00:00Z https://www.cancernetwork.com/view/exploring-the-role-of-radiation-oncology-in-kidney-cancer-awareness-month2026-03-24T12:00:00Z2026-03-24T12:00:00Z https://www.cancernetwork.com/view/can-anti-inflammatory-pathway-targeting-treatment-work-in-early-onset-crc-2026-03-23T20:00:00Z2026-03-23T20:00:00Z https://www.cancernetwork.com/view/considering-venlafaxine-as-distress-treatment-in-breast-cancer2026-03-23T16:15:50.288Z2026-03-23T16:15:50.288Z https://www.cancernetwork.com/view/frontline-sunvozertinib-improves-pfs-vs-chemotherapy-in-egfr-nsclc2026-03-23T14:15:00Z2026-03-23T14:15:00Z https://www.cancernetwork.com/view/when-worlds-collide-how-global-infectious-outbreaks-have-changed-cancer-care2026-03-23T14:00:00Z2026-03-23T14:00:00Z https://www.cancernetwork.com/view/is-it-helping-or-harming-a-clinician-s-guide-to-cannabis-use-in-oncology2026-03-23T12:00:00Z2026-03-23T12:00:00Z https://www.cancernetwork.com/view/patients-under-40-noted-to-have-higher-chemo-induced-nausea-vomiting2026-03-22T20:00:00Z2026-03-22T20:00:00Z https://www.cancernetwork.com/view/could-hematologic-markers-be-prognostic-for-survival-in-rcc-2026-03-22T18:00:00Z2026-03-22T18:00:00Z https://www.cancernetwork.com/view/what-s-the-state-of-immunotherapy-transplantation-in-hematologic-oncology-2026-03-22T16:00:00Z2026-03-22T16:00:00Z https://www.cancernetwork.com/view/3-things-you-should-know-about-squamous-cell-anal-carcinoma2026-03-22T14:00:00Z2026-03-22T14:00:00Z https://www.cancernetwork.com/view/sexual-health-should-be-part-of-aya-survivorship-care2026-03-21T20:00:00Z2026-03-21T20:00:00Z https://www.cancernetwork.com/view/bcma-directed-bispecific-antibodies-navigating-a-new-era-in-relapsed-refractory-multiple-myeloma2026-03-21T14:00:00Z2026-03-21T14:00:00Z https://www.cancernetwork.com/view/inherited-drivers-of-thrombocytosis-platelet-prs-as-rcc-survival-marker2026-03-20T20:00:00Z2026-03-20T20:00:00Z https://www.cancernetwork.com/view/defining-molecular-pathways-across-neuroendocrine-disease-states2026-03-20T17:00:00Z2026-03-20T17:00:00Z https://www.cancernetwork.com/view/fda-approves-nivolumab-avd-in-untreated-hodgkin-lymphoma2026-03-20T16:15:35.675Z2026-03-20T16:15:35.675Z